BlackRock Fund Advisors’s Protara Therapeutics TARA Stock Holding History

BlackRock Fund Advisors’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$44K	Buy	578 +19	+3%	+$6.01K	﹤0.01%	3786
2016 Q3	$209K	Sell	559 -2	-0.4%	-$704	﹤0.01%	3436
2016 Q2	$180K	Sell	561 -4,277	-88%	-$1.28M	﹤0.01%	3488
2016 Q1	$1.5M	Sell	4,838 -278	-5%	-$89.6K	﹤0.01%	3134
2015 Q4	$3.17M	Buy	5,116 +135	+3%	+$79.2K	﹤0.01%	3026
2015 Q3	$2.77M	Buy	4,981 +151	+3%	+$93.5K	﹤0.01%	3046
2015 Q2	$3.45M	Buy	+4,830	New	+$2.99M	﹤0.01%	3063

Other funds holding TARA

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

FCI

Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

BlackRock Fund Advisors's TARA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Protara Therapeutics (TARA) stake by 3.4% in Q4 2016, buying an estimated $6.01K and bringing the position to 578 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #3786.

BlackRock Fund Advisors first reported a position in TARA in Q2 2015 and has held it in 7 quarters since. The position peaked at $3.45M in Q2 2015. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

BlackRock Fund Advisors held 578 shares of Protara Therapeutics worth $44K as of Q4 2016.
BlackRock Fund Advisors bought 19 Protara Therapeutics shares in Q4 2016, an estimated $6.01K.
Protara Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3786 holding.
BlackRock Fund Advisors first reported a position in Protara Therapeutics in Q2 2015 and has held it in 7 quarters since.
BlackRock Fund Advisors's Protara Therapeutics position peaked at $3.45M in Q2 2015.
25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.